| Literature DB >> 34566384 |
Ruchi Vyas1, Garima Sharma1, Devki Sain1, Rashmi Sisodia1.
Abstract
BACKGROUND: Radiation therapy is considered as an important tool in cancer treatment. Despite its impressive role in treating cancer, severe side effects in organs have been reported. To address these therapeutic side effects, several combination methods have been identified to minimize adverse effects caused by radiation therapy. AIMS ANDEntities:
Keywords: Chlorophytum borivilianum; gamma radiation; spermatogenesis; testicular damages
Year: 2021 PMID: 34566384 PMCID: PMC8415242 DOI: 10.4103/ayu.AYU_82_20
Source DB: PubMed Journal: Ayu ISSN: 0974-8520
Animal groups assigned for the current study with their respective specifications
| Groups | Specification |
|---|---|
| Group I (control) | Sham-irradiated animals were given double distilled water through oral gavages once a day for 7 consecutive days (dose equivalent to CBE) |
| Group II | Animals of this group were given double distilled water through oral gavages once a day for 7 consecutive days. On the 7th day, mice were irradiated with 6 Gy gamma radiation |
| Group III | Animals of this group were treated daily once with optimum dose of CBE dissolved in distilled water through oral gavage for 7 consecutive days. On the 7th day, mice were irradiated with 6 Gy gamma radiation |
| Group IV | Animals of this group were treated daily once with optimum dose of CB-AgNPs dissolved in distilled water through oral gavage for 7 consecutive days. On the 7th day, mice were irradiated with 6 Gy gamma radiation |
CBE: Chlorophytum borivilianum extract, CB-AgNPs: Chlorophytum borivilianum-silver nanoparticles
Figure 1Transmission electron microscope image of Chlorophytum borivilianum-silver nanoparticles: (a) high-resolution image of nanocrystals at 10 nm (b) high-resolution image of a single nanocrystal at 2 nm
Respective body weight (g) of mice in experimental groups (values are presented in mean±standard error)
| Day | Group I | Group II | Group III | Group IV |
|---|---|---|---|---|
| 1st | 24.11±1.01 | 18.58±0.64** | 19.1±0.64* | 21.76±0.74* |
| 7th | 26.31±1.08 | 15.21±0.75** | 14.36±0.59** | 18.21±0.65* |
| 15th | 21.39±1.11 | 16.39±0.69** | 18.2±0.78* | 22.36±0.85 |
| 30th | 27.55±1.02 | 11.47±0.54** | 21.55±0.59* | 20.9±0.61* |
*P<0.05, **P<0.01, indicate significant, highly significant, and extremely significant differences, respectively, against Group I (control)
Respective testis weight (g) of mice in experimental groups (values are presented in mean±standard error)
| Group | Days 1 | Days 7 | Days 15 | Days 30 | ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||
| Left | Right | Left | Right | Left | Right | Left | Right | |
| Group I | 111.57±1.32 | 112.21±1.34 | 111.91±1.58 | 110.31±1.62 | 112.16±1.66 | 112.45±1.69 | 111.83±1.59 | 112.99±1.57 |
| Group II | 75.39±1.50** | 74.54±1.52** | 56.72±1.42** | 55.47±1.45*** | 55.58±1.25*** | 57.33±1.21*** | 50.84±1.77*** | 49.65±1.74*** |
| Group III | 81.44±0.72* | 80.19±0.73* | 63.20±0.86** | 62.56±0.82** | 71.80±1.62** | 73.69±1.61** | 88.88±0.62* | 88.91±0.66* |
| Group IV | 89.84±1.82* | 90.48±1.85* | 68.34±1.83** | 67.48±1.84** | 78.60±1.40** | 77.59±1.42** | 96.72±1.21* | 94.15±1.20* |
*P<0.05, **P<0.01, ***P<0.001 indicate significant, highly significant, and extremely significant differences, respectively, against Group I (control)
Figure 2Epididymal sperm count of mice in experimental groups (values are presented in mean ± standard error). *P < 0.05, **P < 0.01, ***P < 0.001 indicate significant, highly significant and extremely significant differences, respectively, against group I (control)
Stereological evaluation of germ cells and Sertoli cells in control and test groups (values are presented in mean±standard error; counts of germ cells are in numbers)
| Day | Group I | Group II | Group III | Group IV |
|---|---|---|---|---|
| Spermatogonia | ||||
| 1 | 21.36±1.50 | 12.71±1.14 | 17.47±1.28 | 16.52±1.31 |
| 7 | 23.17±1.50 | 10.49±1.18 | 15.75±1.34 | 18.41±1.36 |
| 15 | 22.46±1.46 | 9.96±1.09 | 18.37±1.41 | 19.35±1.48 |
| 30 | 25.84±1.62 | 7.85±1.04 | 16.80±1.42 | 20.56±1.45 |
| | - | 0.003** | 0.008** | 0.001** |
| Spermatocytes | ||||
| 1 | 51.28±4.28 | 34.36±4.12 | 38.86±4.20 | 36.29±4.34 |
| 7 | 53.73±4.30 | 28.37±3.98 | 40.91±4.33 | 39.33±4.48 |
| 15 | 58.15±4.42 | 22.54±3.73 | 42.70±4.49 | 47.56±4.54 |
| 30 | 59.24±4.44 | 11.76±3.65 | 44.82±4.54 | 49.37±4.59 |
| | - | 0.009** | 0.000*** | 0.001** |
| Spermatids | ||||
| 1 | 151.66±3.64 | 96.56±3.41 | 111.96±3.10 | 106.88±3.48 |
| 7 | 154.26±3.67 | 72.19±3.28 | 109.71±3.12 | 109.67±3.57 |
| 15 | 156.44±3.74 | 61.24±3.15 | 105.64±3.08 | 115.54±3.61 |
| 30 | 158.33±3.71 | 44.51±3.23 | 114.18±3.19 | 119.56±3.72 |
| | - | 0.003** | 0.000*** | 0.000*** |
| Sertoli cell | ||||
| 1 | 26.43±2.59 | 19.98±2.17 | 22.45±2.43 | 23.65±2.44 |
| 7 | 27.65±2.68 | 14.30±2.26 | 23.63±2.46 | 26.14±2.49 |
| 15 | 29.90±2.72 | 11.52±2.14 | 21.27±2.62 | 27.96±2.52 |
| 30 | 28.25±2.75 | 8.77±2.26 | 24.81±2.76 | 28.55±2.60 |
| | - | 0.008** | 0.012* | 0.053 |
*P<0.05, **P<0.01, ***P<0.001 indicate significant, highly significant, and extremely significant differences, respectively, against Group I (control), SE: Standard error
Figure 3Histological architecture of testis of group I (control) and test groups (II–IV) at various observational days (1, 7, 15 and 30). When compared to control group II animals showed emptied lumen, disintegrated epithelium, vacuole formation, and spermatogonia falling away from Sertoli cells. Leydig cells were found dilated and vacuolation was evident. On the 15th day of observation, most seminiferous tubules lost luminal area (no lumen) and spermatids and spermatocytes were completely disoriented (magnification ×400; H and E). Types A and B spermatogonia (A and B); Spermatocytes (S); Round (R) and Elongated (E) spermatid; Lumen (I); Sertoli cells (SC); Leydig cells (LC)
Figure 4Standard error of the mean image of Chlorophytum borivilianum root extract conjugated silver nanoparticle